1. Home
  2. ARMP vs ANGI Comparison

ARMP vs ANGI Comparison

Compare ARMP & ANGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$5.38

Market Cap

199.7M

Sector

Health Care

ML Signal

HOLD

Logo Angi Inc.

ANGI

Angi Inc.

HOLD

Current Price

$4.72

Market Cap

198.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARMP
ANGI
Founded
N/A
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
198.7M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
ARMP
ANGI
Price
$5.38
$4.72
Analyst Decision
Strong Buy
Buy
Analyst Count
2
7
Target Price
$15.00
$17.00
AVG Volume (30 Days)
82.8K
764.9K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1242.86
EPS
N/A
N/A
Revenue
N/A
$736,386,000.00
Revenue This Year
N/A
$3.25
Revenue Next Year
N/A
$3.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
47.60
52 Week Low
$2.86
$4.26
52 Week High
$14.98
$18.38

Technical Indicators

Market Signals
Indicator
ARMP
ANGI
Relative Strength Index (RSI) 48.40 43.93
Support Level $5.12 $4.55
Resistance Level $5.63 $6.52
Average True Range (ATR) 0.44 0.30
MACD 0.03 0.03
Stochastic Oscillator 48.63 19.08

Price Performance

Historical Comparison
ARMP
ANGI

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

Share on Social Networks: